Search
for

    Did you mean Ischemic Heart Disease?
    GlossaryCoronary Artery Disease (Ischemic Heart Disease)

    narrowing of heart arteries due to plaque buildup

    Coronary Artery Disease (CAD), also known as Coronary Heart Disease (CHD), is a condition where the coronary arteries, which supply blood to the heart muscle, become narrowed or blocked due to the buildup of plaque (atherosclerosis). This can lead to reduced blood flow to the heart, causing chest pain (angina), shortness of breath, or more severe outcomes like heart attacks.

    Related Terms

    Learn

    0 / 0 results
    — no results

    Research

    5 / 1000+ results

    Community Join

    5 / 7 results

      community Ru58841 ruined my life. Here’s why.

      in Product  128 upvotes 2 years ago
      User experienced shortness of breath, high blood pressure, red eyes, and eye floaters after using RU58841 for hair loss. They warn others to avoid RU58841 and stick to finasteride, minoxidil, and dutasteride.

      community Quit vaping/smoking = 80% less loss

      in Research/Science  235 upvotes 8 months ago
      Quitting vaping significantly reduced hair loss for a user who was a heavy vaper and also taking finasteride. Some participants suggest nicotine's vasoconstrictive properties may worsen hair loss, while others share personal anecdotes of hair improvement after quitting smoking or vaping.

      community Atherosclerosis as cause of balding and treatment

      in Treatment  61 upvotes 1 year ago
      Hair loss may be caused by calcification of capillaries in the scalp, restricting blood flow to hair follicles. A daily treatment regimen including high doses of Vitamins D and K, Magnesium, and Nattokinase could potentially decalcify these capillaries, improving blood flow and hair growth. However, some users warn against excessive Vitamin D intake and emphasize the need for medical consultation.

      community Pyrilutamide Phase 3 on its way

      in Treatment  129 upvotes 3 years ago
      Pyrilutamide Phase 3 approved, starting early 2022 with 416 subjects for 24 weeks. Drug potentially better than RU and Breezula, with some users reporting no side effects.